Adolescent Body Mass Index and Cardiovascular Disease-Specific Mortality by Midlife. 2017

Gilad Twig, and Dana Ben-Ami Shor, and Ariel Furer, and Hagai Levine, and Estela Derazne, and Nehama Goldberger, and Ziona Haklai, and Moran Levy, and Arnon Afek, and Adi Leiba, and Jeremy D Kark
Department of Medicine, Sheba Medical Center, Tel Hashomer 5262000, Israel.

As opposed to coronary heart disease (CHD) mortality, cardiovascular mortality attributed to non-CHD causes has increased. To evaluate the association of body mass index (BMI) in late adolescence with mortality attributed to non-CHD cardiovascular sequelae. A nationwide cohort. A total of 2,294,139 adolescents examined between 1967 and 2010. Height and weight were measured at age 17. All cardiovascular disease-specific outcomes, coded by the Central Bureau of Statistics from death notifications as the underlying cause of death, were obtained by linkage. Cox hazards models were applied. Death attributed to fatal arrhythmias, hypertensive heart disease, cardiomyopathies, arterial disease, heart failure, and pulmonary embolism. During 42,297,007 person-years of follow-up, there were 3178 deaths due to cardiovascular causes, of which 279, 122, 121, 114, 94, and 70 were attributed to the main outcomes, respectively. BMI was positively associated with all study outcomes with hazard ratios (HRs) per unit increment in BMI ranging from 1.09 [95% confidence interval (CI): 1.03 to 1.16] for arterial disease to 1.16 (95% CI: 1.11 to 1.21) for hypertensive heart disease. When BMI was treated as a categorical variable, a graded increase in risk was evident from the high-normal (22.0 to <25.0 kg/m2) to the overweight to the obese categories, with HRs of 1.4, 1.7, and 3.7 for arrhythmias; 1.9, 4.1, and 8.0 for hypertensive heart disease; 1.5, 2.4, and 4.0 for cardiomyopathies, 2.7, 5.0, and 3.5; for arterial disease, 1.7, 2.7, and 5.4 for heart failure; and 1.3, 1.8, and 3.0 for pulmonary embolism. Findings persisted in extensive sensitivity analyses. Adolescent BMI within the accepted normal range is associated with non-CHD nonstroke cardiovascular outcomes.

UI MeSH Term Description Entries
D007557 Israel A country in the Middle East, bordering the Mediterranean Sea, between Egypt and Lebanon. The capital is Jerusalem.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009202 Cardiomyopathies A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS). Myocardial Disease,Myocardial Diseases,Myocardial Diseases, Primary,Myocardial Diseases, Secondary,Myocardiopathies,Primary Myocardial Disease,Cardiomyopathies, Primary,Cardiomyopathies, Secondary,Primary Myocardial Diseases,Secondary Myocardial Diseases,Cardiomyopathy,Cardiomyopathy, Primary,Cardiomyopathy, Secondary,Disease, Myocardial,Disease, Primary Myocardial,Disease, Secondary Myocardial,Diseases, Myocardial,Diseases, Primary Myocardial,Diseases, Secondary Myocardial,Myocardial Disease, Primary,Myocardial Disease, Secondary,Myocardiopathy,Primary Cardiomyopathies,Primary Cardiomyopathy,Secondary Cardiomyopathies,Secondary Cardiomyopathy,Secondary Myocardial Disease
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011655 Pulmonary Embolism Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS. Pulmonary Thromboembolism,Thromboembolism, Pulmonary,Embolism, Pulmonary,Embolisms, Pulmonary,Pulmonary Embolisms,Pulmonary Thromboembolisms,Thromboembolisms, Pulmonary
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D002423 Cause of Death Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint. Causes of Death,Death Cause,Death Causes
D005260 Female Females

Related Publications

Gilad Twig, and Dana Ben-Ami Shor, and Ariel Furer, and Hagai Levine, and Estela Derazne, and Nehama Goldberger, and Ziona Haklai, and Moran Levy, and Arnon Afek, and Adi Leiba, and Jeremy D Kark
April 2006, JAMA,
Gilad Twig, and Dana Ben-Ami Shor, and Ariel Furer, and Hagai Levine, and Estela Derazne, and Nehama Goldberger, and Ziona Haklai, and Moran Levy, and Arnon Afek, and Adi Leiba, and Jeremy D Kark
November 2016, Journal of paediatrics and child health,
Gilad Twig, and Dana Ben-Ami Shor, and Ariel Furer, and Hagai Levine, and Estela Derazne, and Nehama Goldberger, and Ziona Haklai, and Moran Levy, and Arnon Afek, and Adi Leiba, and Jeremy D Kark
January 2006, JAMA,
Gilad Twig, and Dana Ben-Ami Shor, and Ariel Furer, and Hagai Levine, and Estela Derazne, and Nehama Goldberger, and Ziona Haklai, and Moran Levy, and Arnon Afek, and Adi Leiba, and Jeremy D Kark
July 2008, Preventive medicine,
Gilad Twig, and Dana Ben-Ami Shor, and Ariel Furer, and Hagai Levine, and Estela Derazne, and Nehama Goldberger, and Ziona Haklai, and Moran Levy, and Arnon Afek, and Adi Leiba, and Jeremy D Kark
April 2018, International journal of obesity (2005),
Gilad Twig, and Dana Ben-Ami Shor, and Ariel Furer, and Hagai Levine, and Estela Derazne, and Nehama Goldberger, and Ziona Haklai, and Moran Levy, and Arnon Afek, and Adi Leiba, and Jeremy D Kark
November 2003, American journal of preventive medicine,
Gilad Twig, and Dana Ben-Ami Shor, and Ariel Furer, and Hagai Levine, and Estela Derazne, and Nehama Goldberger, and Ziona Haklai, and Moran Levy, and Arnon Afek, and Adi Leiba, and Jeremy D Kark
January 2012, Canadian journal of public health = Revue canadienne de sante publique,
Gilad Twig, and Dana Ben-Ami Shor, and Ariel Furer, and Hagai Levine, and Estela Derazne, and Nehama Goldberger, and Ziona Haklai, and Moran Levy, and Arnon Afek, and Adi Leiba, and Jeremy D Kark
April 2018, Obesity (Silver Spring, Md.),
Gilad Twig, and Dana Ben-Ami Shor, and Ariel Furer, and Hagai Levine, and Estela Derazne, and Nehama Goldberger, and Ziona Haklai, and Moran Levy, and Arnon Afek, and Adi Leiba, and Jeremy D Kark
November 2004, Archives of internal medicine,
Gilad Twig, and Dana Ben-Ami Shor, and Ariel Furer, and Hagai Levine, and Estela Derazne, and Nehama Goldberger, and Ziona Haklai, and Moran Levy, and Arnon Afek, and Adi Leiba, and Jeremy D Kark
June 2018, Cardiovascular diabetology,
Copied contents to your clipboard!